SGTX News and Press, Sigilon Therapeutics Inc.

2023-08-14 10:03:16 ET More on Eli Lilly Eli Lilly Remains A Buy With Strong Sales And Possible Upside With Mounjaro Inside Eli Lilly's Strategic Investment In Sigilon: An Opportunity Overlooked Eli Lilly: There Is No Logic To This Over Optimism Eli Lilly: Do...

2023-07-31 18:26:24 ET Summary Pharmaceutical company Eli Lilly and Company is purchasing biotech firm Sigilon Therapeutics, Inc. for $14.92 per share, with shares trading at $21.28 due to a contingent value right from Eli Lilly (potentially). The acquisition, expected to conclude...

NEW YORK, NY / ACCESSWIRE / July 24, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chase Corporation (NYSE:CCF)'s sale...

NEW YORK, NY / ACCESSWIRE / July 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: CIRCOR International, Inc. (NYSE: CIR...

NEW YORK, NY / ACCESSWIRE / July 12, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chinook Therapeutics, Inc. (NAS...

2023-07-10 04:49:51 ET Summary Eli Lilly has seen a massive ramp-up in its diabetes, or better said weight loss, drug Mounjaro. Investors continue to price in further advancements on this front; the question is how much is priced in. I see the reason to get upbeat amidst impre...

2023-06-29 13:50:01 ET Shares of Sigilon Therapeutics Inc ( NASDAQ: SGTX ) soared more than 500% today after Eli Lilly & Co ( NYSE: LLY) said it will buy the biopharmaceutical company in a deal worth up to $309.6 million. Details of the Lilly-Sigilon agreement Lilly ...

Sigilon Therapeutics, Inc. (NASDAQ: SGTX) is one of today's top gainers. The company's shares are currently up 522.51% on the day to $24.34. Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candid...

2023-06-29 07:11:28 ET Shares of Sigilon Therapeutics ( NASDAQ: SGTX ) surged over 650% pre-market Thursday after Eli Lilly ( NYSE: LLY ) agreed to acquire the nano-cap biotech for $14.92 per share in cash, implying a total value of ~$35M. Before the deal, Eli Lill...

Lilly to Acquire Sigilon Therapeutics PR Newswire INDIANAPOLIS and CAMBRIDGE, Mass. , June 29, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) today announced a definitive agreement for Lilly ...